Respiratory Syncytial Virus Vaccine Study

    Not Recruiting
Updated on 15 August 2022
vaccines, rsv
rsv infection


This study will test a new investigational vaccine (referred to as the “study vaccine” in this form) which has not yet been approved for general use in the United States. It means that this vaccine is only given to people who take part in studies that are done to test the vaccine. The investigational vaccine being tested in this study was made to prevent infection from the Respiratory Syncytial Virus (RSV). RSV is a virus that can cause infections of the air passages. In countries with temperate climates, RSV infections are common in winter, the same time as the influenza (flu) season. Most people may not know when they are infected with RSV because the symptoms are very similar to the common cold or flu.


The study will involve 8-10 outpatient visits. All study participants will receive the study vaccine. All study related visits and lab tests are provided at no cost. Compensation for time and travel is provided up to $1000. 

Condition Vaccines, Vaccines, Respiratory Syncytial Virus (RSV) Infection
Clinical Study IdentifierTX264550
Last Modified on15 August 2022

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note